Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019
Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019 Philips is showcasing its latest care innovations the Philips debuts innovations Congress 2019 (European Society Cardiology; 31 August–4 September, At the congress, well robust 3D ventricle volume and ejection measurements, with data trapped different silos that need be reviewed individually, business for Enterprise Diagnostic Informatics Philips. While leading his team on a hospital round, Joshua F. Zeidner, MD, saw a note recommending that arsenic trioxide (Trisenox, Teva) should be temporarily discontinued in a 44-year-old woman with acute promyelocytic leukemia (APL). The recommendation was made according to the product's prescribing information, after a routine ECG reported a QT interval of 400 ms, a heart rate of 95 beats per minute, and a corrected QT (QTc) interval of 503 ms. But should the drug really be stopped because heart arrhythmia treatment of this finding...
Comments
Post a Comment